Пятница, 17.01.2025, 10:37
Приветствую Вас Гость | RSS
Главная | Каталог файлов | Регистрация | Вход
Меню сайта
Категории каталога
Доклады по заболеваниям [128]
Доклады по заболеваниям сделанные на заседаниях кружка.
Клинические разборы [12]
Клинические разборы интересных больных.
Отчеты о мероприятиях [19]
Отчеты о конгрессах,конференциях,заседаниях.
Полезные материалы [193]
Просто материалы заслуживающие внимания.
Статьи [1622]
Клинические исследования [70]
В этой категории будут представлены результаты наиболее интересных недавно завершившихся клинических исследований.
Материалы клинических разборов и занятий с интернами [30]
Материалы предназначенные для интернов
Юный клиницист [10]
Форма входа
Поиск
/
http://www.festivalnauki.ru/
Клиническое подразделение РНМОТ
Гаазовские чтения
Издательство Практика
Доктор на работе
gelaskins.ru
http://medpro.ru/
Друзья сайта
Статистика

Онлайн всего: 1
Гостей: 1
Пользователей: 0
СНО терапии
Главная » Файлы » Статьи

RARRES2, encoding the novel adipokine chemerin, is a genetic determinant of disproportionate regional body fat distribution: comparative mag
[ ] 09.05.2009, 14:12

Abstract

Visceral fat mass is a strong and independent predictor of obesity-related disorders. To date, little is known about the genetic determinants

of regional body fat distribution in humans. As candidates of regional fat distribution, we investigated the fat massand obesity-associated

gene, the peroxisome proliferatoractivated receptorδ gene, and the retinoic acid receptor responder 2 (RARRES2) gene. We studied

whether genetic variation within these genes contributes to the development of disproportionate visceral obesity and obesity-related traits,

such as insulin resistance and β-cell dysfunction. We genotyped 337 subjects with an increased risk for type 2 diabetes mellitus for tagging

single nucleotide polymorphisms (SNPs) in the 3 genes and performed association analyses with anthropometric data and parameters of

insulin sensitivity and β-cell function. All subjects underwent an oral glucose tolerance test; a subset was additionally characterized by a

hyperinsulinemic-euglycemic clamp. Body fat distribution was assessed by nuclear magnetic resonance imaging. The fat massand obesityassociated

gene SNP rs8050136 was nominally associated with body mass index (P = .0130), but not with body fat distribution, after

appropriate adjustment. Magnetic resonance imagingquantified visceral fat mass was significantly associated with RARRES2 SNP

rs17173608 and nominally associated with RARRES2 SNP rs10278590 in nonobese subjects (P = .0002 and P = .0423, respectively), with

carriers of the minor alleles displaying lower visceral adipose tissue mass. Besides, the minor allele of SNP rs17173608 was nominally

associated with a lower waist-to-hip ratio (P = .0295). In obese subjects, these associations were not detected. No associations were found

between the peroxisome proliferatoractivated receptorδ gene and measures of whole-body adiposity and of body fat distribution. All SNPs

were associated neither with insulin sensitivity nor with insulin secretion. Common genetic variation within RARRES2 is associated with

increased visceral fat mass in nonobese subjects. In generalized obesity, this genetic effect may be masked by the close association between

whole-body obesity and visceral fat mass.

© 2009 Elsevier Inc. All rights reserved.

Категория: Статьи | Добавил: nbylova
Просмотров: 403 | Загрузок: 0 | Рейтинг: 0.0/0 |
Всего комментариев: 0
Добавлять комментарии могут только зарегистрированные пользователи.
[ Регистрация | Вход ]
Бесплатный хостинг uCozCopyright MyCorp © 2025